- Funding
- About $400 million from Stryker (Oct 2026)
CMR Surgical is a Cambridge medical devices company that makes Versius, a modular robot for soft-tissue surgery. In October 2026 Stryker agreed to invest about $400 million in preferred equity, became Versius's exclusive US sales agent and took an exclusive option to buy the whole company. CMR keeps development and sales outside the United States.